Monday 26 October 2020
Home      All news      Contact us      RSS     
webmd - 24 days ago

Immunotherapy Drug Helping Lung Cancer Patients

The immunotherapy drug Tecentriq (atezolizumab) was approved earlier this year by the U.S. Food and Drug Administration to treat patients with newly diagnosed non-small cell lung cancers (NSCLC), which comprise up to 85% of all lung tumors.


Latest News
Hashtags:   

Immunotherapy

 | 

Helping

 | 

Cancer

 | 

Patients

 | 

Sources